Literature DB >> 12543542

Comparison of methods of interpretation of checkerboard synergy testing.

Charles R Bonapace1, John A Bosso, Lawrence V Friedrich, Roger L White.   

Abstract

Four different methods for interpreting the results of checkerboard synergy testing were compared by applying each to a set of synergy study data. Statistically significant differences in synergy were detected among methods (% synergy ranged from 10 to 83%). As interpretations were found to vary widely based upon method, one should be aware of this in interpreting the relevant literature.

Mesh：

Substances：

Year:  2002        PMID： 12543542     DOI： 10.1016/s0732-8893(02)00473-x

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  48 in total

1.  An Automated Miniaturized Method to Perform and Analyze Antimicrobial Drug Synergy Assays.

Authors:  Peter Chase; Imarhia Enogieru; Franck Madoux; Eric Bishop; Jacob Beer; Louis Scampavia; Timothy Spicer
Journal:  Assay Drug Dev Technol       Date:  2015-12-15       Impact factor: 1.738

2.  Evaluating aztreonam and ceftazidime pharmacodynamics with Escherichia coli in combination with daptomycin, linezolid, or vancomycin in an in vitro pharmacodynamic model.

Authors:  Kerry L LaPlante; George Sakoulas
Journal:  Antimicrob Agents Chemother       Date:  2009-07-20       Impact factor: 5.191

3.  A Cationic Polymer That Shows High Antifungal Activity against Diverse Human Pathogens.

Authors:  Leslie A Rank; Naomi M Walsh; Runhui Liu; Fang Yun Lim; Jin Woo Bok; Mingwei Huang; Nancy P Keller; Samuel H Gellman; Christina M Hull
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

4.  A lack of synergy between membrane-permeabilizing cationic antimicrobial peptides and conventional antibiotics.

Authors:  Jing He; Charles G Starr; William C Wimley
Journal:  Biochim Biophys Acta       Date:  2014-09-28

5.  Pharmacodynamic and response surface analysis of linezolid or vancomycin combined with meropenem against Staphylococcus aureus.

Authors:  Sebastian G Wicha; Martin G Kees; Janin Kuss; Charlotte Kloft
Journal:  Pharm Res       Date:  2015-01-30       Impact factor: 4.200

6.  In vitro synergism observed with azithromycin, clarithromycin, minocycline, or tigecycline in association with antifungal agents against Pythium insidiosum.

Authors:  Francielli P K Jesus; Laerte Ferreiro; Érico S Loreto; Maiara B Pilotto; Aline Ludwig; Karine Bizzi; Juliana S M Tondolo; Régis A Zanette; Sydney H Alves; Janio M Santurio
Journal:  Antimicrob Agents Chemother       Date:  2014-07-07       Impact factor: 5.191

7.  Activities of antibiotic combinations against resistant strains of Pseudomonas aeruginosa in a model of infected THP-1 monocytes.

Authors:  Julien M Buyck; Paul M Tulkens; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2014-10-27       Impact factor: 5.191

8.  Reshuffling of Aspergillus fumigatus cell wall components chitin and β-glucan under the influence of caspofungin or nikkomycin Z alone or in combination.

Authors:  Patricia E B Verwer; M L van Duijn; M Tavakol; Irma A J M Bakker-Woudenberg; Wendy W J van de Sande
Journal:  Antimicrob Agents Chemother       Date:  2011-12-27       Impact factor: 5.191

Review 9.  Advances in Development of Antimicrobial Peptidomimetics as Potential Drugs.

Authors:  Natalia Molchanova; Paul R Hansen; Henrik Franzyk
Journal:  Molecules       Date:  2017-08-29       Impact factor: 4.411

10.  Quantitative Analyses of Synergistic Responses between Cannabidiol and DNA-Damaging Agents on the Proliferation and Viability of Glioblastoma and Neural Progenitor Cells in Culture.

Authors:  Liting Deng; Lindsay Ng; Tatsuya Ozawa; Nephi Stella
Journal:  J Pharmacol Exp Ther       Date:  2016-11-07       Impact factor: 4.030
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.